SWM
UTHR icon

SHP Wealth Management’s United Therapeutics UTHR Stock Holding History

SHP Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593 Sell
1
-1
-50% -$498 ﹤0.01% 1589
2025
Q4 		$974 Buy
+2
New +$931 ﹤0.01% 1263

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SHP Wealth Management's UTHR Position: Q1 2026 in Review

SHP Wealth Management reduced its United Therapeutics (UTHR) stake by 50% in Q1 2026, selling an estimated $498 and leaving 1 share worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

SHP Wealth Management first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. The position peaked at $974 in Q4 2025. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • SHP Wealth Management held 1 share of United Therapeutics worth $593 as of Q1 2026.
  • SHP Wealth Management sold 1 United Therapeutics share in Q1 2026, an estimated $498.
  • United Therapeutics made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1589 holding.
  • SHP Wealth Management first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's United Therapeutics position peaked at $974 in Q4 2025.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.